Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grant Lee

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Trials|May 18, 2022
Reducing the risk of Plasmodium vivax after falciparum infections in co-endemic areas-a randomized controlled trial (PRIMA)Kamala Thriemer, Tamiru Shibru Degaga, Michael Christian, et al.
The Journal of Pathology|February 13, 2019
Molecular comparison of interval and screen-detected breast cancersDane Cheasley, Na Li, Simone M Rowley, et al.
Lancet (London, England)|November 18, 2023
Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trialKamala Thriemer, Tamiru Shibiru Degaga, Michael Christian, et al.
BMJ Open|January 2, 2020
Measurement challenge: protocol for international case-control comparison of mammographic measures that predict breast cancer riskEvenda Dench, Daniela Bond-Smith, Ellie Darcey, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2025
Systematic analysis of federal funding for spinal cord injury researchTucker Gillespie, Andrew Buxton, Bethany R Kondiles, et al.
Journal of Neurotrauma|November 8, 2025
Funding Distributions, Trends, Gaps, and Policy Implications for Spinal Cord Injury Research: A Systematic Analysis of U.S. Federal FundsTucker Gillespie, Andrew Buxton, Bethany R Kondiles, et al.
The Lancet Regional Health. Western Pacific|June 22, 2026
High-dose, short-course primaquine after point-of-care G6PD testing for the radical cure of <i>Plasmodium vivax</i> malaria: a safety study in Papua New Guinea and IndonesiaLiony Fransisca, Maria Ome-Kaius, Moses Laman, et al.
The Lancet. Infectious Diseases|February 14, 2026
Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trialTamiru Shibiru Degaga, Ayodhia Pitaloka Pasaribu, Rupam Tripura, et al.
Hereditary Cancer in Clinical Practice|October 1, 2022
Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortiumPål Møller, Toni Seppälä, James G Dowty, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Trials|May 18, 2022
Reducing the risk of Plasmodium vivax after falciparum infections in co-endemic areas-a randomized controlled trial (PRIMA)Kamala Thriemer, Tamiru Shibru Degaga, Michael Christian, et al.
The Journal of Pathology|February 13, 2019
Molecular comparison of interval and screen-detected breast cancersDane Cheasley, Na Li, Simone M Rowley, et al.
Lancet (London, England)|November 18, 2023
Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trialKamala Thriemer, Tamiru Shibiru Degaga, Michael Christian, et al.
BMJ Open|January 2, 2020
Measurement challenge: protocol for international case-control comparison of mammographic measures that predict breast cancer riskEvenda Dench, Daniela Bond-Smith, Ellie Darcey, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2025
Systematic analysis of federal funding for spinal cord injury researchTucker Gillespie, Andrew Buxton, Bethany R Kondiles, et al.
Journal of Neurotrauma|November 8, 2025
Funding Distributions, Trends, Gaps, and Policy Implications for Spinal Cord Injury Research: A Systematic Analysis of U.S. Federal FundsTucker Gillespie, Andrew Buxton, Bethany R Kondiles, et al.
The Lancet Regional Health. Western Pacific|June 22, 2026
High-dose, short-course primaquine after point-of-care G6PD testing for the radical cure of <i>Plasmodium vivax</i> malaria: a safety study in Papua New Guinea and IndonesiaLiony Fransisca, Maria Ome-Kaius, Moses Laman, et al.
The Lancet. Infectious Diseases|February 14, 2026
Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trialTamiru Shibiru Degaga, Ayodhia Pitaloka Pasaribu, Rupam Tripura, et al.
Hereditary Cancer in Clinical Practice|October 1, 2022
Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortiumPål Møller, Toni Seppälä, James G Dowty, et al.
Pageof 2